Slate Path Capital LP - Q4 2020 holdings

$1.85 Billion is the total value of Slate Path Capital LP's 30 reported holdings in Q4 2020. The portfolio turnover from Q3 2020 to Q4 2020 was 84.6% .

 Value Shares↓ Weighting
CHTR  CHARTER COMMUNICATIONS INC Ncl a$222,942,000
+6.0%
337,0000.0%12.06%
+0.8%
VTRS NewVIATRIS INC$221,788,00011,835,000
+100.0%
12.00%
NYT BuyNEW YORK TIMES COcl a$200,868,000
+32.6%
3,880,000
+9.6%
10.87%
+26.1%
WMG SellWARNER MUSIC GROUP CORP$170,575,000
+13.5%
4,490,000
-14.1%
9.23%
+7.9%
MOS SellMOSAIC CO NEW$159,689,000
+5.3%
6,940,000
-16.4%
8.64%
+0.2%
FCX SellFREEPORT-MCMORAN INCcl b$150,656,000
+27.9%
5,790,000
-23.1%
8.15%
+21.7%
SFIX SellSTITCH FIX INC$132,942,000
+91.0%
2,264,000
-11.7%
7.19%
+81.7%
MP NewMP MATERIALS CORP$128,680,0004,000,000
+100.0%
6.96%
PAAS SellPAN AMERN SILVER CORP$118,990,000
-11.0%
3,448,000
-17.1%
6.44%
-15.4%
LBRDK  LIBERTY BROADBAND CORP$82,352,000
+10.8%
520,0000.0%4.46%
+5.4%
LNG NewCHENIERE ENERGY INC$59,430,000990,000
+100.0%
3.22%
GOLD SellBARRICK GOLD CORP$37,428,000
-75.3%
1,643,000
-69.5%
2.02%
-76.5%
RTPZU NewREINVENT TECHNOLOGY PARTNERSunit 99/99/9999$19,915,0001,750,000
+100.0%
1.08%
VAPO SellVAPOTHERM INC$19,071,000
-46.2%
710,000
-41.9%
1.03%
-48.8%
CYCN  CYCLERION THERAPEUTICS INC$18,960,000
-49.7%
6,196,0630.0%1.03%
-52.1%
CUE  CUE BIOPHARMA INC$18,560,000
-16.9%
1,483,6190.0%1.00%
-20.9%
NOV NewNATIONAL OILWELL VARCO INC$17,918,0001,305,000
+100.0%
0.97%
SM NewSM ENERGY CO$9,608,0001,570,000
+100.0%
0.52%
CRC NewCALIFORNIA RES CORP$8,492,000360,000
+100.0%
0.46%
X NewUNITED STATES STL CORP NEW$7,714,000460,000
+100.0%
0.42%
CLF NewCLEVELAND-CLIFFS INC NEW$7,280,000500,000
+100.0%
0.39%
OAS NewOASIS PETROLEUM INC$7,041,000190,000
+100.0%
0.38%
PHICU NewPOPULATION HEALTH INVS CO INunit 99/99/9999$5,225,000500,000
+100.0%
0.28%
FVAM New5 01 ACQUISITION CORP$5,085,000500,000
+100.0%
0.28%
EAF NewGRAFTECH INTL LTD$4,637,000435,000
+100.0%
0.25%
LX  LEXINFINTECH HLDGS LTDadr$3,987,000
-2.2%
595,0000.0%0.22%
-6.9%
EEM  ISHARES TRcall$3,152,000
+17.2%
61,0000.0%0.17%
+11.8%
CCJ  CAMECO CORP$2,278,000
+32.7%
170,0000.0%0.12%
+25.5%
KGC  KINROSS GOLD CORP$1,321,000
-16.8%
180,0000.0%0.07%
-21.1%
IAG  IAMGOLD CORP$1,285,000
-4.2%
350,0000.0%0.07%
-7.9%
RIG ExitTRANSOCEAN LTD$0-2,070,000
-100.0%
-0.10%
FVAC ExitFORTRESS VALUE ACQUISITION C$0-330,000
-100.0%
-0.26%
CNX ExitCNX RES CORP$0-500,000
-100.0%
-0.27%
GPRE ExitGREEN PLAINS INC$0-475,000
-100.0%
-0.42%
ALNY ExitALNYLAM PHARMACEUTICALS INC$0-213,000
-100.0%
-1.76%
KEX ExitKIRBY CORP$0-1,296,000
-100.0%
-2.67%
Z ExitZILLOW GROUP INCcl c cap stk$0-773,000
-100.0%
-4.47%
SNAP ExitSNAP INCcl a$0-4,365,000
-100.0%
-6.48%
MYL ExitMYLAN NV$0-10,195,000
-100.0%
-8.60%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2021-02-16
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
CHARTER COMMUNICATIONS INC N30Q3 202315.2%
ALNYLAM PHARMACEUTICALS INC30Q3 20208.9%
UNITED STATES STL CORP NEW24Q3 202311.4%
NEW YORK TIMES CO23Q3 202310.9%
VANECK VECTORS ETF TR21Q3 202319.5%
PAN AMERN SILVER CORP21Q3 20237.6%
CUE BIOPHARMA INC17Q3 20231.3%
BARRICK GOLD CORPORATION16Q4 202015.7%
MOSAIC CO NEW15Q4 202116.8%
MEDICINES CO15Q4 201912.2%

View Slate Path Capital LP's complete holdings history.

Latest significant ownerships (13-D/G)
Slate Path Capital LP Q4 2020 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
Cue Biopharma, Inc.February 14, 20232,402,4555.6%
Stitch Fix, Inc.February 14, 2023? ?
Cyclerion Therapeutics, Inc.January 13, 20237,157,60116.5%
Zimmer Energy Transition Acquisition Corp.February 14, 20222,000,0005.8%
5:01 Acquisition Corp.February 11, 2022500,0005.8%
Hippo Holdings Inc.February 11, 2022350,0000.1%
Warner Music Group Corp.February 11, 20223,134,7792.6%
Reinvent Technology Partners ZFebruary 16, 20211,750,0007.6%

View Slate Path Capital LP's complete significant-ownership history.

Latest filings
TypeFiled
13F-HR2024-02-14
SC 13G/A2024-01-22
13F-HR2023-11-14
13F-HR2023-08-14
13F-HR2023-05-15
SC 13G/A2023-02-14
SC 13G2023-02-14
13F-HR2023-02-14
SC 13G2023-01-13
SC 13G2022-11-18

View Slate Path Capital LP's complete filings history.

Compare quarters

Export Slate Path Capital LP's holdings